IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — CRIS

Balance Sheet

(in billions USD)
MetricQ1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.020.010.010.020.020.010.030.020.020.030.030.030.020.050.080.11
Short-term Investments--------0.000.020.010.040.040.040.070.070.100.080.080.05
Accounts Receivable--0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Total Current Assets0.020.010.010.020.030.030.050.070.070.080.110.110.130.130.160.16
Property, Plant & Equipment0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Goodwill0.010.010.010.010.010.010.010.010.010.010.010.010.010.010.010.01
Total Non-current Assets*0.010.010.010.010.020.020.020.020.020.020.020.020.010.040.020.03
Total Assets0.030.030.030.040.040.050.060.090.080.090.120.130.140.170.180.19
Accounts Payable0.010.000.000.010.000.000.000.010.000.000.010.010.000.000.000.00
Total Current Liabilities0.010.020.020.020.020.020.010.010.010.010.010.010.010.010.010.01
Long-term Debt--------------------------0.000.000.00
Total Non-current Liabilities*0.000.020.020.030.030.030.040.050.050.050.050.050.060.060.060.06
Total Liabilities0.020.040.040.050.050.050.050.060.060.060.070.070.060.070.070.07
Retained Earnings(1.27)(1.27)(1.26)(1.25)(1.23)(1.22)(1.21)(1.18)(1.17)(1.16)(1.14)(1.12)(1.11)(1.08)(1.07)(1.06)
Total Stockholder Equity0.01(0.01)(0.01)(0.01)(0.01)-0.000.010.030.030.040.060.060.080.100.110.12

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Total Revenue0.001.143.182.752.383.352.932.552.092.702.832.202.302.892.832.392.063.143.042.29
Selling, General & Admin5.072.883.653.533.983.353.754.794.894.884.764.254.764.334.565.095.674.774.334.07
Operating Income(11.52)19.62(6.92)(8.25)(10.16)(8.99)(10.57)(12.51)(12.47)(12.20)(12.37)(12.14)(11.63)(10.22)(12.61)(15.06)(15.13)(12.57)(10.05)(10.65)
Net Income(24.20)19.36(7.73)(8.59)(10.62)(9.62)(10.09)(11.80)(11.88)(11.71)(12.18)(11.96)(11.56)(11.33)(13.29)(15.94)(16.11)(13.62)(11.05)(10.84)
Basic EPS(1.25)1.84(0.49)(0.68)(1.25)(1.10)(1.70)(2.03)(2.05)(6.59)(2.13)(0.12)(0.12)1.10(0.14)(0.17)(0.18)(0.15)(0.12)(0.12)
Diluted EPS(1.25)1.84(0.49)(0.68)(1.25)(1.10)(1.70)(2.03)(2.05)(6.59)(2.13)(0.12)(0.12)1.10(0.14)(0.17)(0.18)(0.15)(0.12)(0.12)

Cash Flow Statement

(in millions USD)
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Operating Cash Flow(9.00)(6.37)(5.57)(8.01)(7.25)(9.26)(5.94)(11.13)(13.23)(10.19)(8.18)(7.87)(12.20)(12.27)(13.12)(12.13)(16.82)(8.17)(9.61)(6.66)
Capital Expenditures------------------0.000.000.000.000.000.050.350.010.000.000.00
Free Cash Flow*------------------(10.19)(8.18)(7.87)(12.20)(12.27)(13.17)(12.48)(16.83)(8.17)(9.61)(6.66)
Investing Cash Flow0.002.500.000.000.00(0.43)18.32(7.36)18.9114.520.18(3.15)26.243.464.3028.34(3.08)(3.52)(11.53)(28.77)
Financing Cash Flow18.94(0.12)4.48(2.13)7.548.83(1.52)(1.46)(2.41)(2.12)12.56(0.85)(2.01)(1.39)4.66(0.76)(1.65)(1.31)(0.96)(0.57)

* Derived from reported values